Miyake K, Gotoh M, Sai S
Hinyokika Kiyo. 1985 Feb;31(2):357-64.
Our experience with the use of a new biological tissue adhesive (Tisseel) consisting of highly concentrated human fibrinogen, thrombin and factor XIII in urologic surgery is reported. In 21 operations (18 patients), Tisseel was used for the purpose of tissue adhesion and reduction of sutures of the renal parenchymal wound in nephrolithotomy, water tight sealing in suture part of expanded pyelolithtomy and vasovasostomy, and local hemostasis of oozing in prostatectomized fossa. Tisseel was not responsible for the two unsuccessful trials; and, undesirable complications due to this adhesive were few. Our results revealed that this new fibrin adhesive will be useful for urologic surgery.
本文报道了我们在泌尿外科手术中使用一种新型生物组织粘合剂(Tisseel)的经验,该粘合剂由高浓度人纤维蛋白原、凝血酶和因子 XIII 组成。在21例手术(18例患者)中,Tisseel 用于肾实质伤口的组织粘连和减少缝合,肾盂切开取石术扩张部分缝合处的水密密封和输精管吻合术,以及前列腺切除术后窝渗血的局部止血。两次试验未成功并非 Tisseel 的原因;并且,这种粘合剂引起的不良并发症很少。我们的结果表明,这种新型纤维蛋白粘合剂对泌尿外科手术有用。